CAS: 1056901-62-2 - AT13148
Ref: AN-AG008TDL
| 5mg | 232.00 € | |
| 25mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
AT13148
CAS:1056901-62-2
AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II.
Formula:
C17H16ClN3O
Purity:
99%
Color and Shape:
Solid
Molecular weight:
313.78
Ref: TM-T2482
| 1mg | 48.00 € | |
| 2mg | 67.00 € | |
| 5mg | 117.00 € | |
| 10mg | 189.00 € | |
| 25mg | 329.00 € | |
| 50mg | 476.00 € | |
| 1ml*10 (DMSO) | 125.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
(S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol
CAS:1056901-62-2
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
313.7900085449219
Ref: 10-F459624
| 1g | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 28 May 2024
AT-13148
Controlled ProductCAS:1056901-62-2
Formula:
C17H16ClN3O
Color and Shape:
Neat
Molecular weight:
313.781
Ref: TR-A790350
| 25mg | 20,214.00 € |
Estimated delivery in United States, on Friday 28 Jun 2024
AT 13148
CAS:1056901-62-2
Inhibitor of ROCK I and ROCK II kinases; multi-AGC kinase inhibitor
Purity:
Min. 95%
Ref: 3D-FA137648
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
